Article
Quality of Life After Definitive Linear Accelerator-Based Stereotactic Radiotherapy for Prostate Cancer: A Longitudinal Study
2022-03-09
Abstract excerpt
<h4>Background: </h4> Prostate cancer is the second most common malignancy worldwide, and the majority of patients are diagnosed with localized disease. We examined patients’ quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer. Method We included patients who were treated between 2016 and 2020. Inclusion criteria were adenocarcinoma of the prostate; class risk of low, intermediate...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 42a1f350-bab5-5ba0-ad08-fe57d8af26d1
- DOI
- 10.21203/rs.3.rs-1036625/v2
